SF3B1 and cervical cancer: By identifying new factors such as SF3B1 and EIF4G3, which show increased mRNA expression and altered methylation patterns in cervical cancer and precursor lesions, the research underscores the potential of these genes as biomarkers for early detection and diagnostic precision.